Type 2 diabetes mellitus and kidney cancer risk: A retrospective cohort analysis of the National Health Insurance

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Tseng, Chin Hsiao ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; END STAGE RENAL DISEASE; FEMALE; HUMAN; KIDNEY CANCER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; RISK FACTOR; TAIWAN; COMPLICATION; DIABETES MELLITUS, TYPE 2; INCIDENCE; KIDNEY NEOPLASMS; MIDDLE AGED; ODDS RATIO; PUBLIC HEALTH; STATISTICAL MODEL;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84955475058     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142480     Document Type: Article

References (50)

1. Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012; 2012:789174. doi: 10.1155/2012/789174 PMID: 22701472
2. Tseng CH. Pioglitazone and bladder cancer: a population-based study of Taiwanese. Diabetes Care. 2012; 35:278-280. doi: 10.2337/dc11-1449 PMID: 22210574
3. Tseng CH. A review on thiazolidinediones and bladder cancer in human studies. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2014; 32:1-45. doi: 10.1080/10590501.2014.877645 PMID: 24598039
4. Tseng CH. Diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan. Acta Diabetol. 2013; 50:879-886. doi: 10.1007/s00592-013-0471-0 PMID: 23508375
5. Tseng CH. Diabetes and non-Hodgkin's lymphoma: Analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan. Ann Oncol. 2012; 23:153-158. doi: 10.1093/annonc/mdr334 PMID: 21765043
6. Chen HF, Liu MD, Chen P, Chen L.H., Chang YH, Wen PC, et al. Risks of breast and endometrial cancer in women with diabetes: a population-based cohort study. PLoSOne. 2013; 8:p. PMID: 23826297
7. Lin CM, Huang HL, Chu F.Y., Fan HC, Chen HA, Chu DM, et al. Association between gastroenterological malignancy and diabetes mellitus and anti-diabetic therapy: a nationwide, population-based cohort study. PLoSOne. 2015; 10:e0125421. doi: 10.1371/journal.pone.0125421 PMID: 25978841
8. Song S, Wang B, Zhang X., Hao L, Hu X, Li Z., et al. Long-term diabetes mellitus is associated with an increased risk of pancreatic cancer: a meta-analysis. PLoSOne. 2015; 10:e0134321. doi: 10.1371/journal.pone.0134321 PMID: 26222906
9. Xu X, Wu J, Mao Y., Zhu Y, Hu Z, Xu X., et al. Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies. PLoSOne. 2013; 8:e58079. doi: 10.1371/journal.pone.0058079 PMID: 23472134
10. Zhu Z, Zhang X, Shen Z, Zhong S, Wang X, Lu Y, et al. Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies. PLoS One. 2013; 8:e56662. doi: 10.1371/journal.pone.0056662 PMID: 23437204
11. Yang WS, Li HL, Xu H.L., Yang G., Gao YT, Zheng W, et al. Type 2 diabetes and the risk of non-Hodgkin's lymphoma: a report from two population-based cohort studies in China. Eur J Cancer Prev. 2015 Mar 19. [Epub ahead of print]. PMID: 25793918
12. Zucchetto A, Dal Maso L, Tavani A, Montella M, Ramazzotti V, Talamini R, et al. History of treated hypertension and diabetes mellitus and risk of renal cell cancer. Ann Oncol. 2007; 18:596-600. PMID: 17158772
13. Szablewski L. Diabetes mellitus: influences on cancer risk. Diabetes Metab Res Rev. 2014; 30:543-553. doi: 10.1002/dmrr.2573 PMID: 25044584
14. Tseng CH. Diabetes and risk of prostate cancer: A study using the National Health Insurance. Diabetes Care. 2011; 34:616-621. doi: 10.2337/dc10-1640 PMID: 21273499
15. Wang M, Hu RY, Wu H.B., Pan J., Gong WW, Guo LH, et al. Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China. Sci Rep. 2015; 5:11503. doi: 10.1038/srep11503 PMID: 26082067
16. Hsieh MC, Lee TC, Cheng S.M., Tu ST, Yen MH, Tseng CH. The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res. 2012; 2012:413782. doi: 10.1155/2012/413782 PMID: 22719752
17. Tseng CH. Prostate cancer mortality in Taiwanese men: Increasing age-standardized trend in general population and increased risk in diabetic men. Ann Med. 2011; 43:142-150. doi: 10.3109/07853890.2010.530683 PMID: 21284526
18. Ljungberg B, Campbell SC, Choi H.Y., Jacqmin D., Lee JE, Weikert S, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011; 60:615-621. doi: 10.1016/j.eururo.2011.06.049 PMID: 21741761
19. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010; 7:245-257. doi: 10.1038/nrurol.2010.46 PMID: 20448658
20. Wang G, Hou J, Ma L, Xie J, Yin J, Xu D, et al. Risk factor for clear cell renal cell carcinoma in Chinese population: a case-control study. Cancer Epidemiol. 2012; 36:177-182. doi: 10.1016/j.canep.2011.09.006 PMID: 22000673
21. Setiawan VW, Stram DO, Nomura A.M., Kolonel LN, Henderson BE. Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol. 2007; 166:932-940. PMID: 17656615
22. Wideroff L, Gridley G, Mellemkjaer L., Chow WH, Linet M, Keehn S, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997; 89:1360-1365. PMID: 9308706
23. Lindblad P, Chow WH, Chan J, Bergström A, Wolk A, Gridley G, et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia. 1999; 42:107-112. PMID: 10027588
24. Larsson SC, Wolk A. Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia. 2011; 54:1013-1018. doi: 10.1007/s00125-011-2051-6 PMID: 21274512
25. Bao C, Yang X, Xu W, Luo H., Xu Z, Su C, et al. Diabetes mellitus and incidence and mortality of kidney cancer: a meta-analysis. J Diabetes Complications. 2013; 27:357-364. doi: 10.1016/j.jdiacomp.2013.01.004 PMID: 23433629
26. Inoue M, Iwasaki M, Otani T., Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006; 166:1871-1877. PMID: 17000944
27. Khan M, Mori M, Fujino Y., Shibata A, Sakauchi F, Washio M, et al.; Japan Collaborative Cohort Study Group. Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev. 2006; 7:253-259. PMID: 16839219
28. Jee SH, Ohrr H, Sull J.W., Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005; 293:194-202. PMID: 15644546
29. Kuriki K, Hirose K, Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev. 2007; 16:83-89. PMID: 17220709
30. PLOS Medicine Editors. Observational studies: getting clear about transparency. PLoS Med. 2014; 11: e1001711. doi: 10.1371/journal.pmed.1001711 PMID: 25158064
31. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al.; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007; 4:e297. PMID: 17941715
32. STROBE (2007) STROBE checklists, Version 4 as published in Oct/Nov 2007. Available: http://www.strobe-statement.org/index.php?id=available-checklists. Accessed August 18, 2015.
33. Cho E, Adami HO, Lindblad P. Epidemiology of renal cell cancer. Hematol Oncol Clin North Am. 2011; 25:651-665. doi: 10.1016/j.hoc.2011.04.002 PMID: 21763961
34. Zendehdel K, Nyrén O, Ostenson C.G., Adami HO, Ekbom A, Ye W. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst. 2003; 95:1797-1800. PMID: 14652242
35. Lai SW, Liao KF, Lai H.C., Tsai PY, Sung FC, Chen PC. Kidney cancer and diabetes mellitus: a population-based case-control study in Taiwan. Ann Acad Med Singapore. 2013; 42:120-124. PMID: 23604500
36. Lin CC, Chiang JH, Li C.I., Liu CS, Lin WY, Hsieh TF, et al. Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan. BMC Cancer. 2014; 14:381. doi: 10.1186/1471-2407-14-381 PMID: 24884617
37. Liu X, Hemminki K, Försti A, Sundquist K., Sundquist J, Ji J. Cancer risk in patients with type 2 diabetes mellitus and their relatives. Int J Cancer. 2015; 137:903-910. doi: 10.1002/ijc.29440 PMID: 25604005
38. Harding JL, Shaw JE, Peeters A, Cartensen B., Magliano DJ. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care. 2015; 38:264-270. doi: 10.2337/dc14-1996 PMID: 25488912
39. Oberaigner W, Ebenbichler C, Oberaigner K, Juchum M, Schönherr HR, Lechleitner M. Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria. BMC Public Health. 2014; 14:1058. doi: 10.1186/1471-2458-14-1058 PMID: 25300498
40. Tseng CH. Incidence of type 1 diabetes mellitus in children aged 0-14 years during 1992-1996 in Taiwan. Acta Pediatr. 2008; 97:392-393.
41. Jiang YD, Chang CH, Tai T.Y., Chen JF, Chuang LM. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database. J Formos Med Assoc. 2012; 111:599-604. doi: 10.1016/j.jfma.2012.09.014 PMID: 23217595
42. IDF Diabetes Atlas, sixth edition. http://www.idf.org/sites/default/files/EN6EAtlasFull-0.pdf (last accessed July 1,2015).
43. Tseng CH, Tseng CP, Chong C.K., Huang TP, Song YM, Chou CW, et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 2006; 49:1755-1760. PMID: 16788802
44. Chiang CJ, Chen YC, Chen C.J., You SL, Lai MS; Taiwan Cancer Registry Task Force. Cancer trends in Taiwan. Jpn J Clin Oncol. 2010; 40:897-904. doi: 10.1093/jjco/hyq057 PMID: 20495192
45. Cumberbatch MG, Rota M, Catto J.W., La Vecchia C. The Role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol. 2015 Jul 3. pii: S0302-2838(15)00548-5. doi: 10.1016/j.eururo.2015.06.042 [Epub ahead of print] PMID: 26149669
46. Pearce N, Checkoway H, Kriebel D. Bias in occupational epidemiology studies. Occup Environ Med. 2007; 64:562-568. PMID: 17053019
47. Blot WJ, Fraumeni JF Jr. Geographic patterns of renal cancer in the United States. J Natl Cancer Inst. 1979; 63:363-366. PMID: 287829
48. Bidoli E, Franceschi S, Dal Maso L, Guarneri S, Barbone F. Cancer mortality by urbanization and altitude in a limited area in Northeastern Italy. Rev Epidemiol Sante Publique. 1993; 41:374-382. PMID: 8284477
49. Yang CY, Hsieh YL. The relationship between population density and cancer mortality in Taiwan. Jpn J Cancer Res. 1998; 89:355-360. PMID: 9617339
50. Health Promotion Administration, Ministry of Health and Welfare. Cancer Registry Annual Report, 2012. Taiwan http://www.hpa.gov.tw/BHPNet/Web/Stat/StatisticsShow.aspx?No=201504290001 (last accessed July 1, 2015).